BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 10022928)

  • 1. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
    You M; Yu DH; Feng GS
    Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways.
    Min W; Pober JS; Johnson DR
    Circ Res; 1998 Oct; 83(8):815-23. PubMed ID: 9776728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
    Kim HY; Park EJ; Joe EH; Jou I
    J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.
    David M; Chen HE; Goelz S; Larner AC; Neel BG
    Mol Cell Biol; 1995 Dec; 15(12):7050-8. PubMed ID: 8524272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
    You M; Zhao Z
    J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation and maintenance of CNTF-Jak/STAT signaling in neurons is blocked by protein tyrosine phosphatase inhibitors.
    Jiao J; Kaur N; Lu B; Reeves SA; Halvorsen SW
    Brain Res Mol Brain Res; 2003 Aug; 116(1-2):135-46. PubMed ID: 12941469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
    Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
    J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interferon alfa signaling components in human alcoholic liver disease.
    Nguyen VA; Gao B
    Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control mechanism of JAK/STAT signal transduction pathway.
    Yamada S; Shiono S; Joo A; Yoshimura A
    FEBS Lett; 2003 Jan; 534(1-3):190-6. PubMed ID: 12527385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
    Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
    Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
    Kim H; Hawley TS; Hawley RG; Baumann H
    Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.
    Pang Q; Fagerlie S; Christianson TA; Keeble W; Faulkner G; Diaz J; Rathbun RK; Bagby GC
    Mol Cell Biol; 2000 Jul; 20(13):4724-35. PubMed ID: 10848598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
    Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
    J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.